In the pharmaceutical industry, systematic literature reviews (SLRs) can be a valuable tool — not just for regulatory submissions, but as a strategic foundation for drug development, clinical trial design, and commercialization, feasibility, supporting IND/NDA filings, and identifying unmet needs. Understanding the full scope of their strategic value can help teams align evidence generation with business objectives and regulatory demands.
In this webinar, our experts will show how pharmaceutical companies can unlock the full potential of SLRs to support regulatory requirements, inform internal decision-making, and improve competitive positioning. Using real-world pharmaceutical-focused examples, we’ll discuss when and how to deploy an SLR, and the benefits of working with experienced external partners like Criterion Edge to streamline timelines and elevate quality.
- Understand the Strategic Role of SLRs in Pharmaceutical and Combination Device Development
Learn how SLRs support regulatory filings while also guiding early-stage development, clinical planning, and lifecycle management. Understanding the full scope of their strategic value can help teams align evidence generation with business objectives and regulatory demands.
- Design an SLR That Serves Both Regulatory and Commercial Goals
Discover how a well-designed search methodology improves evidence quality and generates insights that can also be leveraged by cross-functional teams—from R&D and Medical Affairs to Sales and Marketing. For executives overseeing cross-functional teams, aligning SLR outputs to multiple internal stakeholders increases the ROI of evidence generation efforts and reduces redundancy.
- Know When to Bring in the Experts
Identify when your internal team may benefit from partnering with an experienced team like Criterion Edge to ensure scientific rigor, regulatory alignment, and delivery of publication- or submission-ready outputs. Understanding when and why to outsource can help executives mitigate delays and improve quality across submissions, strategy decks, and decision-support materials.
